Lori Mills from Simi Valley, CA, delivers passionate testimony at the FDA’s Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing on June 4, 2026, in Washington, D.C. Fighting for her husband Andrew’s life after his glioblastoma (GBM) diagnosis, she shares their miracle story and demands nationwide release of ANKTIVA (N-803) and NK cell therapies for all cancer patients – not just as a last resort.
Hundreds of patients are reaching out. This is about hope, real access, Right to Try, and cutting red tape. Share if you or a loved one has been impacted by cancer.
#ANKTIVA #FDAReform